İçeriğe geç
Global sound
Talking Rheumatology Research

Talking Rheumatology Research

Ep 38. Is risankizumab safe and effective for active psoriatic arthritis? Results from the KEEPsAKE 2 study

· 8 dk · Bölüm 38

Bölüm notları

Dr Andrew Östör joins Dr Marwan Bukhari to discuss their article, chosen as the June Editor's Choice article, which evaluates the 52-week efficacy and safety of risankizumab 150 mg in patients with active PsA who had previous inadequate response/intolerance to one or two biologic therapies (Bio-IR) or one or more conventional synthetic DMARDs (csDMARD-IR). Listen now to hear the findings and what this means for future clinical practice! You can read this article [https://doi.org/10.1093...

★ Artist of the week The fastest riser on the radio this week
Your song here? From € 9 per week →
DIRTY30 RADIODinlemeye devam et